These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2933460)

  • 21. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
    Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
    Tamura GS; McGrath MS; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin-dependent helper T cells: studies in the MOPC-315 system suggest a novel surface antigen phenotype.
    Rohrer JW; Kemp JD
    J Immunol; 1986 Sep; 137(6):1786-92. PubMed ID: 2943802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of a murine B cell lymphoma with monoclonal antibodies and IL 2.
    Berinstein N; Levy R
    J Immunol; 1987 Aug; 139(3):971-6. PubMed ID: 3496394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a hybridoma-derived T cell factor that promotes the production of antibodies bearing a dominant cross-reactive idiotype(s).
    Wardzala AM; Bowen MB; Jendrisak GS; Bellone CJ
    J Mol Cell Immunol; 1986; 2(5):243-53. PubMed ID: 2978231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
    Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
    Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ly-1 B helper cells in autoimmune "viable motheaten" mice.
    Sherr DH; Dorf ME; Gibson M; Sidman CL
    J Immunol; 1987 Sep; 139(6):1811-7. PubMed ID: 2957439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas.
    Thielemans K; Maloney DG; Meeker T; Fujimoto J; Doss C; Warnke RA; Bindl J; Gralow J; Miller RA; Levy R
    J Immunol; 1984 Jul; 133(1):495-501. PubMed ID: 6609992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells.
    Gricks CS; Rawlings E; Foroni L; Madrigal JA; Amlot PL
    Cancer Res; 2001 Jul; 61(13):5145-52. PubMed ID: 11431353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiotype- and anti-idiotype-reactive T lymphocytes in myasthenia gravis. Evidence for the involvement of different subpopulations of T helper lymphocytes.
    Yi Q; Lefvert AK
    J Immunol; 1994 Oct; 153(7):3353-9. PubMed ID: 8089503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of antigen-specific suppressor T lymphocytes in man involves dual recognition of self class I MHC molecules and Leu-4/T3-associated structures on the surface of inducer T lymphocytes.
    Damle NK; Mohagheghpour N; Engleman EG
    J Immunol; 1984 Sep; 133(3):1235-40. PubMed ID: 6205073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants.
    Starnes CO; Carroll WL; Campbell MJ; Houston LL; Apell G; Levy R
    J Immunol; 1988 Jul; 141(1):333-9. PubMed ID: 3132505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.
    Bertinetti C; Zirlik K; Heining-Mikesch K; Ihorst G; Dierbach H; Waller CF; Veelken H
    Cancer Res; 2006 Apr; 66(8):4496-502. PubMed ID: 16618777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy of lymphoma directed at idiotypes.
    Levy R; Miller RA
    J Natl Cancer Inst Monogr; 1990; (10):61-8. PubMed ID: 1693283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional and biochemical evidence for the recognition of T cell receptors by monoclonal antibodies to an immunoglobulin idiotype.
    Martínez C; Bragado R; de la Hera A; Toribio ML; Marcos MA; Bandeira A; Pereira P; Coutinho A
    J Mol Cell Immunol; 1986; 2(6):307-13. PubMed ID: 2978235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
    George AJ; Tutt AL; Stevenson FK
    J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses.
    Lowder JN; Meeker TC; Campbell M; Garcia CF; Gralow J; Miller RA; Warnke R; Levy R
    Blood; 1987 Jan; 69(1):199-210. PubMed ID: 2431729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of "host cell infiltrates" in patients with follicular lymphoma with and without spontaneous regression.
    Strickler JG; Copenhaver CM; Rojas VA; Horning SJ; Warnke RA
    Am J Clin Pathol; 1988 Sep; 90(3):257-61. PubMed ID: 2970792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.
    Foon KA
    N Engl J Med; 1982 Sep; 307(11):686-7. PubMed ID: 6981064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.